Abstract
A new Slovak speech database EWA-DB was created for research purposes aimed at early detection of neurodegenerative diseases from speech. It contains 1649 speakers performing various speech and language tasks, such as sustained vowel phonation, diadochokinesis, naming and picture description. The sample of speakers consists of individuals with Alzheimer’s disease, mild cognitive impairment, Parkinson’s disease, and healthy controls. In this article we describe the EWA-DB development process, the language and speech task selection, patient and healthy control recruitment, as well as the testing and recording protocol. The structure and content of the database and file formats are described in detail. We assume that the presented database could be suitable for the development of automatic systems predicting the diagnoses of Alzheimer’s disease, mild cognitive impairment, and Parkinson’s disease from language and speech features.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was created in relation to the project EWA - Early Warning of Alzheimer (ITMS2014+ : 313022V631), which was funded by the European Regional Development Fund and the project ALOIS - Diagnosis of Alzheimer's disease from speech using artificial intelligence and social robotics (APVV-21-0373), which was funded by the Slovak Research and Development Agency.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Bratislava self-governing region (Bratislavský samosprávny kraj) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data presented in the present work are publicly available at ELRA/ELDA under the name EWA-DB Early Warning of Alzheimer speech database. (2023)
https://catalog.elra.info/en-us/repository/browse/ELRA-S0489/
